Kategorien
-
Adhesives
6
Amines
115
Amino Acids
210
Analytical Reagents
751
Antibiotics
275
Bioactive Small Molecules
806
Aroma Chemicals
247
Biochemicals
1158
Boronic Acids
4
Buffers
105
Building Blocks
2196
Carbohydrates
193
Catalysts
120
Chiral Compounds
77
Coccus nucifera oil
0
Detergents
63
Diagnostic Raw Materials
273
Flavours and Fragrance Materials
236
Fluorinated Products
68
Furans
7
Gases in Solution
53
Grignard Reagents
32
HPLC Reagents
8
Imidazoles
19
Indoles
48
Inorganic Chemicals
360
Ion-Pair Reagents
21
Ligands
81
Organics
1651
Oxazoles
3
Peptide Reagents
102
Phenols
55
Picolines
0
Piperazines
13
Pyrazines
3
Pyridines
69
Pyrimidines
36
Quaternary Ammonium salts
45
Reagents
114
Research Organics & Inorganics
895
Salts
311
Sealing Compounds
1
Sherclin
1
Solvents
134
Stains & Indicators
324
Sugars
67
Tailor-made solutions
1
Testing Standards
4
Uncategorised
18
Water Analysis
12
Domiphen bromide
(79548603 | 538-71-6)
CAS: | 538-71-6 |
---|---|
Molekularformel: | C22H40BrNO |
Molekulargewicht: | 414.46 |
Verfügbarkeit: | Auf Lager |
---|---|
Downloads: | Produktspezifikation | Sicherheitsdatenblatt [EN] |
79548603-25g | 25g | £42.90 | |
Bulk Menge |
79548603-25g | 25g | €60.10 | |
Bulk Menge |
79548603-25g | 25g | $64.40 | |
Bulk Menge |
Sicherheitsdatenblatt
Analysezertifikat
Produktbeschreibung
Product Code | 79548603 | ||||
Product Name | Domiphen bromide | ||||
Categories | Biochemicals Building Blocks Quaternary Ammonium salts | ||||
CAS | 538-71-6 | ||||
Molecular Formula | C22H40BrNO | ||||
Molecular Weight | 414.46 | ||||
Storage Details | Ambient | ||||
Harmonised Tariff Code | 29239000 |
Produktspezifikation
Melting Point | 108°C~118°C | ||||
Grade | BP | ||||
pH | 5.0 ~ 7.0 | ||||
Loss on Drying | <1% | ||||
Assay | >98% | ||||
Residue on Ignition | <0.1% | ||||
Appearance | Light yellow or white flake crystal | ||||
Production Date | TBC | ||||
Non quaternary ammonium compounds | <0.5 ml/g |
Sicherheitsinformation
Pictograms |
|
||||
Signal word | warning | ||||
Hazard statements |
|
||||
Precautionary statements |
|